id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-E-0311-0005,FDA,FDA-2005-E-0311,Determination of Regulatory Review Period for Purposes of Patent Extension; TARCEVA,Notice,General Notice,2006-09-29T04:00:00Z,2006,9,2006-09-29T04:00:00Z,,2025-12-03T00:32:04Z,E6-15987,0,0,090000648044781c
FDA-2005-E-0311-0004,FDA,FDA-2005-E-0311,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2006-09-11T04:00:00Z,2006,9,,,2025-12-03T00:28:49Z,,0,0,0900006480447819